Aurinia Pharmaceuticals Inc (AUPH)

[Ganz]

FDA approval is inevitable, AUPH hasn’t produced a s succession of strong balance sheets and most investors won’t buy until that happens. Like most others on this board, I thought there was going to be a short run the end of December/ first week of January,...we’ll see, but I can honestly say, I don’t believe anything will stop AUPH from January 22 approval.